0001209191-12-000410.txt : 20120103 0001209191-12-000410.hdr.sgml : 20120102 20120103162128 ACCESSION NUMBER: 0001209191-12-000410 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20111229 FILED AS OF DATE: 20120103 DATE AS OF CHANGE: 20120103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANGER ROBERT CENTRAL INDEX KEY: 0001239757 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52089 FILM NUMBER: 12502309 MAIL ADDRESS: STREET 1: 98 MONTVALE RD CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVIVO THERAPEUTICS HOLDINGS CORP. CENTRAL INDEX KEY: 0001292519 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 475-1520 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Design Source, Inc. DATE OF NAME CHANGE: 20040602 4 1 c26350_4x1.xml MAIN DOCUMENT DESCRIPTION X0304 4 2011-12-29 0001292519 INVIVO THERAPEUTICS HOLDINGS CORP. NVIV 0001239757 LANGER ROBERT 98 MONTVALE ROAD NEWTON MA 02459 0 0 1 0 COMMON STOCK, $0.00001 PAR VALUE 2011-12-29 4 S 0 165247 2.489 D 8097113 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.45 to $2.66, inclusive. The reporting person undertakes to provide InVivo Therapeutics Holdings Corp. ("InVivo"), any security holder of InVivo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1. /S/ ELIZABETH FRASER, ATTORNEY-IN-FACT 2012-01-03 EX-24 2 c26350_24.htm POWER OF ATTORNEY Power of Attorney
Power of Attorney
I, Robert Langer, the undersigned, hereby constitute and appoint Bradley Jacobson, Robert Puopolo, Elizabeth Fraser, and Abdullah Malik, and each of them individually, as my true and lawful attorney-in-fact to:
1. Complete and execute on my behalf, as a stockholder and member of the Scientific Advisory Board of InVivo Therapeutics Holdings Corp., a Nevada corporation (the “Company”), Forms 3, 4, or 5 required to be filed by me under Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules and regulations thereunder;
2. Do and perform any and all acts for and on my behalf which may be necessary or desirable to complete and execute any such Forms 3, 4 or 5 and timely file such forms with the U.S. Securities and Exchange Commission and any stock exchange or similar authority; and
3. Take any other action of any type whatsoever in connection with the foregoing, which in the opinion of such attorney-in-fact may be of benefit to, in the best interest of, or legally required of me, it being understood that the documents executed by such attorney-in-fact on my behalf pursuant to this Power of Attorney shall be in such form and shall contain such information as such attorney-in-fact may approve in such attorney-in-fact’s discretion.
I hereby grant to each of such attorneys-in-fact full power and authority to do and perform all and every act which is necessary, proper or desirable to be done in the exercise of any of the rights, powers and authority granted in this Power of Attorney, with full power of substitution and revocation, and I ratify and confirm every act that such attorney-in-fact lawfully performs or causes to be done by virtue of this Power of Attorney and the powers and authority granted herein.
I acknowledge that the attorneys-in-fact appointed in this Power of Attorney, in serving in such capacity at my request, are not assuming, and the Company is not assuming, any of my responsibilities to comply with Section 16 of the Exchange Act or the rules or regulations thereunder.
This Power of Attorney shall remain in full force and effect until I am no longer required to file Forms 3, 4 or 5 with respect to my holdings or transactions in securities issued by the Company, unless I earlier revoke this Power of Attorney in a signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of
December 30, 2011.
/s/ Robert Langer                    
Print Name: Robert Langer